Showing results (51-60 of 2,396) with videos related to
Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|July 21, 2022
Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906Miwako Nozaki, Yoshikazu Kagami, Mitsuhiro Takahashi, et al.Breast Cancer (Tokyo, Japan)|September 14, 2018
Expression of the RAC1, RHOA and CXCR4 proteins and their interaction as risk factors for infiltration to the nipple areola complex in operable breast carcinomaYusuf Heriady, Dimyati Achmad, Bethy S Hernowo, et al.Breast Cancer (Tokyo, Japan)|February 28, 2019
Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese populationHaruru Kotani, Hidemi Ito, Kazuhiko Kuwahara, et al.Breast Cancer (Tokyo, Japan)|November 16, 2018
Breast cancer risk associated with BRCA1/2 variants in the Pakistani populationSaba Abbas, Ayesha Siddique, Naeem Shahid, et al.Breast Cancer (Tokyo, Japan)|November 18, 2018
Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancerRong Wang, Jinbin Li, Chunyu Yin, et al.Breast Cancer (Tokyo, Japan)|November 18, 2018
Clinicopathological features of breast cancer in Japanese female patients with Lynch syndromeNobuhiko Kanaya, Kohji Tanakaya, Rie Yamasaki, et al.Breast Cancer (Tokyo, Japan)|January 22, 2021
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtypeYuko Tanaka, Takashi Ohno, Taichi Kadonaga, et al.Breast Cancer (Tokyo, Japan)|February 18, 2021
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort studyKiyo Tanaka, Norikazu Masuda, Naoki Hayashi, et al.Breast Cancer (Tokyo, Japan)|February 9, 2021
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancerTomohiro Ochi, Hiroko Tsunoda, Naoko Matsuda, et al.Breast Cancer (Tokyo, Japan)|February 22, 2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulinXiaozhong Teng, Tetsu Hayashida, Takeshi Murata, et al.Pageof 240